𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biological Modification of protracted infusion of 5-fluorouracil with weekly leucovorin

✍ Scribed by Cynthia Gail Leichman; Lawrence Leichman; C. Paul Spears; Peter J. Rosen; Franco Muggia; Susan Jeffers; William Waugh

Book ID
105663669
Publisher
Springer
Year
1990
Tongue
English
Weight
502 KB
Volume
26
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I study of 5-fluorouracil administ
Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy
✍ James A. Martenson; Thomas G. Shanahan; Michael J. O'Connell; Charles D. Cobau; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

## BACKGROUND. This study was designed to assess the toxicity of pelvic radiation therapy, 5-fluorouracil (5-FU) administered by protracted venous infusion, and leucovorin. ## METHODS. Pelvic radiation therapy consisted of 50.4 -54 gray (Gy) administered in 28 -30 fractions. Systemic treatment

A phase II trial of weekly high dose con
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer